RNAi therapies for HCPs
RNAi therapies for HCPs

OXLUMO® (lumasiran) - RNAi Therapy

Select below to explore educational, scientific and clinical resources related to the licensed uses of our therapies in the UK

  OXLUMO® (lumasiran)

View Prescribing Information

Explore clinical and educational resources related to the use of lumasiran in patients in all age groups with primary hyperoxaluria type 1 (PH1).

Resources

Patient Treatment Guide – Paediatric
icon Title

OXLUMO (lumasiran) Patient Treatment Guide – Paediatric

icon Material type

PDF

icon Description

A treatment guide to be given to caregivers of paediatric patients who are prescribed OXLUMO. This guide covers what PH1 is, what OXLUMO is and other information about the treatment. Healthcare professionals should refer to the Prescribing Information for full details on lumasiran.

Preparation Date
March 2026
Job Code
MB-UK-00147
oxlumo adult
icon Title

OXLUMO (lumasiran) Patient Treatment Guide – Adult

icon Material type

PDF

icon Description

A treatment guide to be given to adult patients who are prescribed OXLUMO. This guide covers what PH1 is, what OXLUMO is and other information about the treatment. Healthcare professionals should refer to the Prescribing Information for full details on lumasiran.

Preparation Date
March 2026
Job Code
MB-UK-00148

Explore Additional Resources & Support

Attr

Primary Hyperoxaluria Type 1 (PH1)

To learn about Primary Hyperoxaluria Type 1 (PH1) therapeutic area

Right Arrow
Medical call icon representing healthcare communication

Didn't Find What You Were Looking For?

Contact our medical team for scientific information, support, and resources.

Right Arrow
Preparation Date
January 2026
Job Code
MB-UK-00033